Erytech Pharma presents research into novel technology

Lyon, France-based biotech firm Erytech Pharma (Euronext: ERYP) is to present new research at the European Red Cell Research Society (ERCS) in Switzerland.

Erytech is working on innovative therapies which encapsulate drug substances inside red blood cells using its ERYCAPS process.

The firm says the research it will present at ERCS confirms the notion that the ERYCAPS process “does not significantly alter the properties of RBCs and that apart from the encapsulated drug substance, RBC-based therapeutics produced using this process have similar characteristics to that of unprocessed packed RBCs.”